New-onset systemic sclerosis and scleroderma renal crisis under docetaxel.

Docetaxel chemotherapy drug-induced autoimmune disease paraneoplastic scleroderma systemic sclerosis

Journal

Journal of scleroderma and related disorders
ISSN: 2397-1991
Titre abrégé: J Scleroderma Relat Disord
Pays: England
ID NLM: 101685427

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 10 02 2021
accepted: 07 03 2021
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: ppublish

Résumé

Systemic sclerosis is a rare systemic autoimmune disease characterized by microvascular impairment and fibrosis of the skin and other organs with poor outcomes. Toxic causes may be involved. We reported the case of a 59-year-old woman who developed an acute systemic sclerosis after two doses of adjuvant chemotherapy by docetaxel and cyclophosphamide for a localized hormone receptor + human epithelial receptor 2-breast cancer. Docetaxel is a major chemotherapy drug used in the treatment of breast, lung, and prostate cancers, among others. Scleroderma-like skin-induced changes (morphea) have been already described for taxanes. Here, we report for the first time a case of severe lung and kidney flare with thrombotic microangiopathy after steroids for acute interstitial lung disease probably induced by anti-RNA polymerase III + systemic sclerosis after docetaxel.

Identifiants

pubmed: 35387214
doi: 10.1177/23971983211007669
pii: 10.1177_23971983211007669
pmc: PMC8922668
doi:

Types de publication

Case Reports

Langues

eng

Pagination

306-310

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Int J Dermatol. 2016 Jan;55(1):97-100
pubmed: 25266415
Ugeskr Laeger. 1994 Jan 10;156(2):162-4
pubmed: 7905216
Ann Dermatol Venereol. 2018 Jan;145(1):33-36
pubmed: 28917576
Int J Dermatol. 1989 Apr;28(3):177-9
pubmed: 2523364
Clin Dermatol. 1998 May-Jun;16(3):353-66
pubmed: 9642529
Cancer. 2002 Feb 1;94(3):847-53
pubmed: 11857321
Am J Ther. 2011 Sep;18(5):e167-71
pubmed: 20592666
J Cutan Pathol. 2018 Aug;45(8):615-618
pubmed: 29740855
Mayo Clin Proc. 2017 Jul;92(7):1158-1163
pubmed: 28599746
Int J Rheum Dis. 2017 Nov;20(11):1835-1837
pubmed: 26179887
Clin Exp Dermatol. 2012 Oct;37(7):755-8
pubmed: 22439735
Cutis. 1989 Apr;43(4):365-8
pubmed: 2731442
Br J Dermatol. 2007 Jan;156(1):182-3
pubmed: 17199595
Annu Rev Nutr. 1992;12:235-56
pubmed: 1503805
J Rheumatol. 1997 Jun;24(6):1242
pubmed: 9195548
Br J Dermatol. 2005 Jul;153(1):224-5
pubmed: 16029366
Cureus. 2016 Jun 30;8(6):e663
pubmed: 27493845
Br J Dermatol. 2002 Aug;147(2):385-6
pubmed: 12174121
Br J Dermatol. 1987 Jan;116(1):95-100
pubmed: 3814517
Scand J Rheumatol. 1990;19(1):87-90
pubmed: 2309108
Case Reports Immunol. 2017;2017:4249157
pubmed: 28265474
J Am Acad Dermatol. 2004 Aug;51(2 Suppl):S73-6
pubmed: 15280817
J Am Acad Dermatol. 2000 Mar;42(3):519-20
pubmed: 10688731
J Dermatol. 2012 May;39(5):482-4
pubmed: 21955042
Autoimmun Rev. 2020 Aug;19(8):102596
pubmed: 32540450
Rheumatology (Oxford). 1999 Apr;38(4):379-80
pubmed: 10378723
J Rheumatol. 1984 Apr;11(2):254
pubmed: 6726731
Clin Exp Dermatol. 2005 Mar;30(2):141-5
pubmed: 15725240
Ann Intern Med. 1990 Mar 1;112(5):344-51
pubmed: 2306063
Br J Dermatol. 2007 Feb;156(2):363-7
pubmed: 17223879
J Am Acad Dermatol. 1980 Jan;2(1):47-55
pubmed: 7354151
Joint Bone Spine. 2016 May;83(3):330-4
pubmed: 26433710
Arch Dis Child. 1975 Aug;50(8):658-61
pubmed: 812426
J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):332-3
pubmed: 1918474
J Dermatol. 2016 Sep;43(9):1071-4
pubmed: 26992088
Med Cutan Ibero Lat Am. 1985;13(4):353-6
pubmed: 3912638

Auteurs

Véronique Debien (V)

Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Arthur Petitdemange (A)

Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (RESO), Tertiary Center for Primary Immunodeficiency, Strasbourg University Hospital, Strasbourg, France.

Dorothée Bazin (D)

Department of Nephrology, Strasbourg University Hospital, Strasbourg, France.

Carole Ederle (C)

Department of Pneumology, Strasbourg University Hospital, Strasbourg, France.

Benoit Nespola (B)

Department of Immunobiology, Strasbourg University Hospital, Strasbourg, France.

Hamid Merdji (H)

Hôpitaux universitaires de Strasbourg, Intensive Care Unit, Nouvel Hôpital Civil, Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.

Jérome Olagne (J)

Department of Nephrology, Strasbourg University Hospital, Strasbourg, France.
Department of Pathology, Strasbourg University Hospital, Strasbourg, France.

Thierry Martin (T)

Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (RESO), Tertiary Center for Primary Immunodeficiency, Strasbourg University Hospital, Strasbourg, France.
Université de Strasbourg, INSERM UMR-S1109, GENOMAX platform, Fédération Hospitalo-Universitaire OMICARE, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Strasbourg, France.

Aurélien Guffroy (A)

Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (RESO), Tertiary Center for Primary Immunodeficiency, Strasbourg University Hospital, Strasbourg, France.
Université de Strasbourg, INSERM UMR-S1109, GENOMAX platform, Fédération Hospitalo-Universitaire OMICARE, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Strasbourg, France.

Carole Pflumio (C)

Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Classifications MeSH